Background: Delay in recognition and treatment of inflammatory neuropathies increases morbidity and mortality. We have developed and standardized 3 clinical screening criteria that rapidly detect inflammatory neuropathies.   Methods: We reviewed all patients with definite large fiber neuropathy in 2 different patient populations: 1 from a private...

Several treatments are available to help ease Alzheimer’s symptoms; however, none of these existing treatments are capable of slowing the progression of the disease and protecting the brain from further damage. Clinical researches are developing new treatments that may slow the progression of Alzheimer’s. The SUVN-502...

Clinicians working with stroke survivors believe that post-stroke rehabilitation works, but the evidence base to convince a wider audience is lacking. There are several contributory factors for this. First, we do not know how much of an intervention to provide, although the differences in outcome...

ABSTRACT Objective: To estimate the risks for cancer (overall and site-specific) in an amyotrophic lateral sclerosis (ALS) cohort. Methods: In this observational longitudinal study, ALS and cancer cases were identified in a computerized Utah genealogy database (Utah Population Database) linked to a statewide cancer registry and death...